Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	protein-DNA complex organization	FAM47A BDP1 ZFP42 CENPT CHAF1A DLGAP5 CHD9 JADE1 TRIP12 CREBBP TASOR2 PHF2 MKI67 AHR TBR1 DOT1L UHRF2 TSPYL4 SPTY2D1	1.15e-05	999	127	19	GO:0071824
GeneOntologyBiologicalProcess	nuclear export	RANGAP1 CTDSPL2 RANBP3 NCBP3 POM121 MDN1 AKAP13 LTV1	1.94e-05	185	127	8	GO:0051168
GeneOntologyCellularComponent	chromosome, centromeric region	PDS5B RANGAP1 CENPT CREBBP PHF2 CHMP7 NCAPD2 MKI67 UHRF2 TOP2A	8.46e-06	276	129	10	GO:0000775
GeneOntologyCellularComponent	condensed chromosome	RANGAP1 CENPT CREBBP PHF2 CHMP7 LIG3 NCAPD2 MKI67 TOP2A	1.24e-04	307	129	9	GO:0000793
GeneOntologyCellularComponent	chromosomal region	PDS5B RANGAP1 CENPT CREBBP PHF2 CHMP7 NCAPD2 MKI67 UHRF2 TOP2A	2.88e-04	421	129	10	GO:0098687
GeneOntologyCellularComponent	acrosomal vesicle	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1 IFT88 ICA1L SPESP1	2.95e-04	206	129	7	GO:0001669
GeneOntologyCellularComponent	transcription elongation factor complex	ELOA AFF3 CCNT1 CCNL1	3.97e-04	56	129	4	GO:0008023
GeneOntologyCellularComponent	inhibitory synapse	IQSEC3 IGSF9 BSN	9.09e-04	31	129	3	GO:0060077
GeneOntologyCellularComponent	cytoplasmic side of plasma membrane	EPN3 CYLD ANK2 DTNA CHMP7 ATP2B1	1.02e-03	185	129	6	GO:0009898
GeneOntologyCellularComponent	cytoskeleton of presynaptic active zone	RIMS4 BSN	1.03e-03	8	129	2	GO:0048788
GeneOntologyCellularComponent	condensed chromosome, centromeric region	RANGAP1 CENPT CREBBP PHF2 CHMP7 NCAPD2	1.27e-03	193	129	6	GO:0000779
Domain	CCDC74	CCDC74B CCDC74A	4.52e-05	2	126	2	IPR033226
Domain	CCDC74_C	CCDC74B CCDC74A	4.52e-05	2	126	2	IPR029422
Domain	CCDC74_C	CCDC74B CCDC74A	4.52e-05	2	126	2	PF14917
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A5	6.31e-05	12	126	3	PF15371
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A5	6.31e-05	12	126	3	IPR027970
Domain	ZF_ZZ_2	DTNA CREBBP HERC2	2.27e-04	18	126	3	PS50135
Domain	ZF_ZZ_1	DTNA CREBBP HERC2	2.27e-04	18	126	3	PS01357
Domain	ZZ	DTNA CREBBP HERC2	2.27e-04	18	126	3	PF00569
Domain	Znf_ZZ	DTNA CREBBP HERC2	2.68e-04	19	126	3	IPR000433
Domain	ZnF_ZZ	DTNA CREBBP HERC2	2.68e-04	19	126	3	SM00291
Domain	Alpha_kinase	ALPK3 ALPK2	6.65e-04	6	126	2	PF02816
Domain	MHCK_EF2_kinase	ALPK3 ALPK2	6.65e-04	6	126	2	IPR004166
Domain	ALPHA_KINASE	ALPK3 ALPK2	6.65e-04	6	126	2	PS51158
Domain	Alpha_kinase	ALPK3 ALPK2	6.65e-04	6	126	2	SM00811
Domain	CYCLINS	CCNE1 CCNT1 CCNL1	8.68e-04	28	126	3	PS00292
Domain	Cyclin_L/T	CCNT1 CCNL1	1.23e-03	8	126	2	IPR015429
Domain	Cyclin_N	CCNE1 CCNT1 CCNL1	1.41e-03	33	126	3	PF00134
Domain	Cyclin_N	CCNE1 CCNT1 CCNL1	1.41e-03	33	126	3	IPR006671
Domain	ZU5	ANK2 ANK3	1.58e-03	9	126	2	SM00218
Domain	PHD	INTS12 JADE1 PHF2 UHRF2	1.66e-03	75	126	4	PF00628
Domain	ZU5	ANK2 ANK3	1.96e-03	10	126	2	PS51145
Domain	Znf_PHD-finger	INTS12 JADE1 PHF2 UHRF2	2.01e-03	79	126	4	IPR019787
Domain	CYCLIN	CCNE1 CCNT1 CCNL1	2.13e-03	38	126	3	SM00385
Domain	-	CCNE1 CCNT1 CCNL1	2.47e-03	40	126	3	1.10.472.10
Domain	ZU5	ANK2 ANK3	2.85e-03	12	126	2	PF00791
Domain	ZU5_dom	ANK2 ANK3	2.85e-03	12	126	2	IPR000906
Domain	Cyclin-like	CCNE1 CCNT1 CCNL1	3.04e-03	43	126	3	IPR013763
Domain	PHD	INTS12 JADE1 PHF2 UHRF2	3.10e-03	89	126	4	SM00249
Domain	Znf_FYVE_PHD	INTS12 JADE1 PHF2 BSN UHRF2	3.21e-03	147	126	5	IPR011011
Domain	Znf_PHD	INTS12 JADE1 PHF2 UHRF2	3.36e-03	91	126	4	IPR001965
Domain	-	INTS12 ZNF423 JADE1 TTC3 MAP3K1 PHF2 MID1 BSN UHRF2	3.42e-03	449	126	9	3.30.40.10
Domain	ZF_PHD_2	INTS12 JADE1 PHF2 UHRF2	3.92e-03	95	126	4	PS50016
Domain	Znf_RING/FYVE/PHD	INTS12 ZNF423 JADE1 TTC3 MAP3K1 PHF2 MID1 BSN UHRF2	3.95e-03	459	126	9	IPR013083
Domain	ZF_PHD_1	INTS12 JADE1 PHF2 UHRF2	4.07e-03	96	126	4	PS01359
Domain	TF_T-box	TBR1 MGA	5.75e-03	17	126	2	IPR001699
Domain	Cyclin_C-dom	CCNE1 CCNL1	5.75e-03	17	126	2	IPR004367
Domain	TBOX	TBR1 MGA	5.75e-03	17	126	2	SM00425
Domain	TF_T-box_CS	TBR1 MGA	5.75e-03	17	126	2	IPR018186
Domain	-	TBR1 MGA	5.75e-03	17	126	2	2.60.40.820
Domain	Cyclin_C	CCNE1 CCNL1	5.75e-03	17	126	2	PF02984
Domain	TBOX_3	TBR1 MGA	5.75e-03	17	126	2	PS50252
Domain	T-box	TBR1 MGA	5.75e-03	17	126	2	PF00907
Domain	TBOX_1	TBR1 MGA	5.75e-03	17	126	2	PS01283
Domain	Cyclin_C	CCNE1 CCNL1	5.75e-03	17	126	2	SM01332
Domain	TBOX_2	TBR1 MGA	5.75e-03	17	126	2	PS01264
Domain	aa-tRNA-synth_I_CS	EPRS1 LARS2	6.44e-03	18	126	2	IPR001412
Domain	Rib_L2_dom2	HERC2 UHRF2	6.44e-03	18	126	2	IPR014722
Domain	-	HERC2 UHRF2	6.44e-03	18	126	2	2.30.30.30
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	PDS5B ELOA CENPT INTS12 CTDSPL2 CHAF1A DLGAP5 POU2F1 CHD9 SYNPO RREB1 ARHGAP11A TRIP12 NCBP3 PHF2 CCNT1 MSH6 LIG3 CCNL1 ZSCAN18 MKI67 HERC2 DOT1L UHRF2 MGA TOP2A	4.19e-20	608	131	26	36089195
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	PDS5B CENPT CTDSPL2 CHAF1A CHD9 TRIP12 JMY PHF2 CCNT1 MSH6 LIG3 ZNF800 RBM25 MDN1 MKI67 HERC2 TBR1 MGA TOP2A	1.75e-13	533	131	19	30554943
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	PDS5B ELOA AFF3 CHD9 ARHGAP11A CREBBP CCNT1 MSH6 MDN1 ZNF516 MGA SPTY2D1	5.53e-11	222	131	12	37071664
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	FAM47A EPRS1 RANGAP1 DGKA MAGI3 ARHGAP11A GPRIN1 TRIP12 BIRC6 MSH6 LIG3 IGF2BP3 MDN1 TRPM3 CEP95 AHR AKAP13 TBR1	3.77e-10	736	131	18	29676528
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1	2.87e-09	6	131	4	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1	2.87e-09	6	131	4	25930072
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	PDS5B EPRS1 ELOA RANGAP1 CENPT CHAF1A DLGAP5 RREB1 TRIP12 TASOR2 NCBP3 PHF2 CCNT1 LIG3 RBM25 EIF5 MKI67 MGA TOP2A	3.48e-09	954	131	19	36373674
Pubmed	A human MAP kinase interactome.	ABL2 ANK3 CHAF1A SYNPO NCKAP5L CREBBP ASAP2 POM121 CEP95 MAP4K5 NAV3 AKAP13 HERC2 MGA	4.96e-09	486	131	14	20936779
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PDS5B EPRS1 ELOA RANGAP1 CHAF1A DLGAP5 POU2F1 RREB1 GPRIN1 TRIP12 MSH6 RBM25 MDN1 CCNL1 ZNF516 MKI67 TOP2A	5.97e-09	774	131	17	15302935
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	PDS5B EPRS1 RANGAP1 ZNF185 DLGAP5 TRIP12 BIRC6 CREBBP CCNT1 MSH6 LIG3 MDN1 MAP4K5 NCAPD2 MKI67 AKAP13 LTV1 HERC2 MGA ATP2B1 RAB13 TOP2A	7.32e-09	1353	131	22	29467282
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	EPRS1 RANGAP1 ABL2 ANK2 ANK3 DTNA MAGI3 GPRIN1 ADCY9 RBM25 MAP4K5 NCAPD2 EIF5 PDZD8 LTV1 ATP2B1	1.16e-08	708	131	16	39231216
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	PDS5B EPRS1 ELOA RANGAP1 INTS12 ANK2 CTDSPL2 DTNA CHAF1A DGKA MAGI3 SYNPO TTC3 TRIP12 TASOR2 PSME3IP1 MDN1 IFT88 NCAPD2 BSN ATP2B1 TOP2A	2.28e-08	1442	131	22	35575683
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CYLD RANGAP1 ANK2 ANK3 DTNA RANBP3 GPRIN1 TTC3 NCKAP5L ADCY9 NCBP3 CHMP7 MDN1 MAP4K5 PPP1R15B PEX19 TMEM131L PDZD8 AKAP13 LTV1 HERC2 ATP2B1	3.92e-08	1487	131	22	33957083
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EPRS1 ELOA RANGAP1 ANK2 RANBP3 DLGAP5 GPRIN1 CCNT1 CRACD PSME3IP1 MSH6 LIG3 IGF2BP3 EIF5 MKI67 LTV1 TOP2A	9.08e-08	934	131	17	33916271
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ANK3 CTDSPL2 RANBP3 TRIP12 MAP3K1 TASOR2 ASAP2 POM121 MAP4K5 AKAP13 BSN MGA	9.24e-08	430	131	12	35044719
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	RANGAP1 CENPT DLGAP5 ARHGAP11A MSH6 NCAPD2 MKI67 SMN1 TOP2A	1.12e-07	210	131	9	16565220
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RANGAP1 DLGAP5 SYNPO JADE1 ARHGAP11A SHOC2 ADCY9 AFAP1 ZNF516 NCAPD2 TMEM131L IGSF9 BSN	1.14e-07	529	131	13	14621295
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	RANGAP1 INTS12 CHAF1A POU2F1 TRIP12 CREBBP CRACD PSME3IP1 LIG3 FOXD3 MDN1 NCAPD2 NHEJ1 MGA ATP2B1 TOP2A	1.59e-07	857	131	16	25609649
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	PDS5B ELOA TRIP12 BIRC6 MAP3K1 NCBP3 MSH6 LIG3 IGF2BP3 MDN1 MKI67 LTV1 HERC2 SPTY2D1 TOP2A	1.94e-07	759	131	15	35915203
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ELOA RANGAP1 ANK3 CTDSPL2 DTNA GPRIN1 SHOC2 NCKAP5L BIRC6 ADCY9 PHF2 MSH6 PEX19 MKI67 PDZD8 HERC2 ATP2B1	4.63e-07	1049	131	17	27880917
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	INTS12 TASOR2 MKI67 UHRF2 MGA TOP2A	9.35e-07	86	131	6	37253089
Pubmed	Interaction network of human early embryonic transcription factors.	ZNF423 POU2F1 RREB1 CREBBP LIG3 ZNF516 MKI67 UHRF2 MGA TOP2A	9.44e-07	351	131	10	38297188
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	EPN3 JADE1 LARS2 TTC3 BIRC6 ADCY9 CCNE1 DACT1 MDN1 PPP1R15B ZNF516 NCAPD2 PDZD8 AKAP13 LTK HERC2 DOT1L	9.45e-07	1105	131	17	35748872
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	EPRS1 RANGAP1 ANK3 RANBP3 GPRIN1 CREBBP MSH6 RBM25 NCAPD2 DOT1L MGA TOP2A	1.23e-06	549	131	12	38280479
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	ELOA RANBP3 TRIP12 CCNT1 MSH6 LIG3 MKI67 MGA TOP2A	1.37e-06	283	131	9	30585729
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	PDS5B ELOA CHAF1A CHD9 CREBBP CCNT1 PSME3IP1 MSH6 LIG3 RBM25 MDN1 NCAPD2 MKI67 NHEJ1 UHRF2 TOP2A	1.46e-06	1014	131	16	32416067
Pubmed	Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage.	ELOA ZNF423 MSH6 AFAP1 POM121 MKI67 TOP2A	1.65e-06	149	131	7	25184681
Pubmed	Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.	RANGAP1 GPRIN1 ADCY9 MSH6 IGF2BP3 MDN1 EIF5 TMEM131L PDZD8 ATP2B1	1.71e-06	375	131	10	32788342
Pubmed	Human transcription factor protein interaction networks.	CYLD INTS12 DTNA POU2F1 RREB1 CREBBP PHF2 LIG3 IGF2BP3 RBM25 ZNF516 ZSCAN18 MKI67 SMN1 LTV1 HERC2 TBR1 DOT1L MGA	1.80e-06	1429	131	19	35140242
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1	1.93e-06	24	131	4	32212159
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	EPRS1 CHAF1A DLGAP5 TRIP12 CHMP7 MSH6 RBM25 NCAPD2 MKI67 AKAP13 TOP2A	3.46e-06	503	131	11	16964243
Pubmed	Primary cilia and Gli3 activity regulate cerebral cortical size.	KITLG IFT88 MKI67 TBR1	4.24e-06	29	131	4	21976438
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	PDS5B EPRS1 INTS12 POU2F1 CHD9 RREB1 CREBBP PHF2 CCNT1 MSH6 IGF2BP3 ZNF516 EIF5 MKI67 UHRF2 TOP2A	4.28e-06	1103	131	16	34189442
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ELOA CHAF1A DLGAP5 RREB1 NCKAP5L BIRC6 ADCY9 MID1 PEX19 TMEM131L PDZD8 AKAP13 MGA	4.33e-06	733	131	13	34672954
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	ABL2 ANK2 CHAF1A TGOLN2 LIG3 ASAP2 MAP4K5 MKI67 FLACC1	4.68e-06	329	131	9	17474147
Pubmed	Tagging genes with cassette-exchange sites.	ZFP42 ZNF423 JADE1 TRIP12 BIRC6 CREBBP PEX19 MKI67 AKAP13	5.41e-06	335	131	9	15741177
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	ANK2 ANK3 MKI67	6.15e-06	10	131	3	22159418
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	PDS5B RANGAP1 RANBP3 NCBP3 CCNT1 LIG3 NCAPD2 MKI67 SMN1	6.24e-06	341	131	9	32971831
Pubmed	A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells.	RANGAP1 PSME3IP1 POM121 EIF5 MKI67 TOP2A	6.86e-06	121	131	6	22412018
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	EPRS1 DLGAP5 CCNT1 MSH6 LIG3 IGF2BP3 RBM25 MKI67 MGA TOP2A	7.15e-06	441	131	10	31239290
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	PDS5B RANGAP1 TRIP12 BIRC6 TASOR2 MSH6 IGF2BP3 RBM25 MDN1 NCAPD2 MKI67 HERC2	7.22e-06	653	131	12	22586326
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	RANGAP1 ZNF185 SYNPO CREBBP CCNT1 PSME3IP1 LIG3 EIF5 MGA TOP2A	7.58e-06	444	131	10	34795231
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	EPRS1 RANGAP1 INTS12 CTDSPL2 CHAF1A DLGAP5 RREB1 ARHGAP11A TRIP12 PHF2 LIG3 RBM25 MDN1 MKI67 MGA SPTY2D1 TOP2A	7.76e-06	1294	131	17	30804502
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	PDS5B EPRS1 RANGAP1 TRIP12 NCBP3 LIG3 IGF2BP3 RBM25 POM121 MDN1 MKI67 HERC2 MGA ATP2B1 TOP2A	7.77e-06	1024	131	15	24711643
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	PDXDC1 CYLD ANK3 GPRIN1 TRIP12 BIRC6 ADCY9 TASOR2 IGF2BP3 PPP1R15B MKI67 MGA SPTY2D1	8.08e-06	777	131	13	35844135
Pubmed	The association of microcephaly protein WDR62 with CPAP/IFT88 is required for cilia formation and neocortical development.	IFT88 MKI67 TBR1	8.43e-06	11	131	3	31816041
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	EPRS1 TRIP12 MSH6 NCAPD2 AKAP13 HERC2 TBR1	1.22e-05	202	131	7	33005030
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	PDS5B INTS12 ZNF423 POU2F1 JADE1 PHF2 MSH6 ZNF516 SEBOX AHR SMN1 UHRF2 MGA	1.22e-05	808	131	13	20412781
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	XIRP1 ZFP42 CTDSPL2 CHAF1A SYNPO MDN1 TRPM3 ZNF516 EIF5 AKAP13 TBR1 MGA	1.23e-05	689	131	12	36543142
Pubmed	In utero and lactational exposure to a complex mixture of polychlorinated biphenyls: toxicity in pups dependent on the Cyp1a2 and Ahr genotypes.	CYP1A2 AHR	1.41e-05	2	131	2	20961953
Pubmed	Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1.	LIG3 TDP1	1.41e-05	2	131	2	15744309
Pubmed	Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.	CYP1A2 AHR	1.41e-05	2	131	2	16538170
Pubmed	TDP1 is required for efficient non-homologous end joining in human cells.	TDP1 NHEJ1	1.41e-05	2	131	2	29078113
Pubmed	Interactions between the aryl hydrocarbon receptor and P-TEFb. Sequential recruitment of transcription factors and differential phosphorylation of C-terminal domain of RNA polymerase II at cyp1a1 promoter.	CCNT1 AHR	1.41e-05	2	131	2	12917420
Pubmed	Phenobarbital induces cytochrome P4501A2 hnRNA, mRNA and protein in the liver of C57BL/6J wild type and aryl hydrocarbon receptor knock-out mice.	CYP1A2 AHR	1.41e-05	2	131	2	9559668
Pubmed	Neoadjuvant therapy in microsatellite-stable colorectal carcinoma induces concomitant loss of MSH6 and Ki-67 expression.	MSH6 MKI67	1.41e-05	2	131	2	28232158
Pubmed	Reactive oxygen species stress increases accumulation of tyrosyl-DNA phsosphodiesterase 1 within mitochondria.	LIG3 TDP1	1.41e-05	2	131	2	29523818
Pubmed	TDP1 serine 81 promotes interaction with DNA ligase IIIalpha and facilitates cell survival following DNA damage.	LIG3 TDP1	1.41e-05	2	131	2	20009512
Pubmed	CCDC74A/B are K-fiber crosslinkers required for chromosomal alignment.	CCDC74B CCDC74A	1.41e-05	2	131	2	31521166
Pubmed	Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care.	MKI67 TOP2A	1.41e-05	2	131	2	27175798
Pubmed	Ahrd Cyp1a2(-/-) mice show increased susceptibility to PCB-induced developmental neurotoxicity.	CYP1A2 AHR	1.41e-05	2	131	2	22935098
Pubmed	Genetic differences in the aryl hydrocarbon receptor and CYP1A2 affect sensitivity to developmental polychlorinated biphenyl exposure in mice: relevance to studies of human neurological disorders.	CYP1A2 AHR	1.41e-05	2	131	2	29197979
Pubmed	The value of immunohistochemical determination of topoisomerase IIα and Ki67 as markers of cell proliferation and malignant transformation in colonic mucosa.	MKI67 TOP2A	1.41e-05	2	131	2	24185119
Pubmed	A Cyp1a2-luciferase transgenic CD-1 mouse model: responses to aryl hydrocarbons similar to the humanized AhR mice.	CYP1A2 AHR	1.41e-05	2	131	2	15329440
Pubmed	Direct interaction of DNA repair protein tyrosyl DNA phosphodiesterase 1 and the DNA ligase III catalytic domain is regulated by phosphorylation of its flexible N-terminus.	LIG3 TDP1	1.41e-05	2	131	2	34181949
Pubmed	The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes.	ANK2 ANK3	1.41e-05	2	131	2	11781319
Pubmed	Structural basis of diverse membrane target recognitions by ankyrins.	ANK2 ANK3	1.41e-05	2	131	2	25383926
Pubmed	Markers of proliferation and invasiveness in somatotropinomas.	MKI67 TOP2A	1.41e-05	2	131	2	29334118
Pubmed	Hydrostatic pressure regulates CYP1A2 expression in human hepatocytes via a mechanosensitive aryl hydrocarbon receptor-dependent pathway.	CYP1A2 AHR	1.41e-05	2	131	2	32159360
Pubmed	A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.	CCNT1 DOT1L	1.41e-05	2	131	2	17855633
Pubmed	In utero and lactational exposure to PCBs in mice: adult offspring show altered learning and memory depending on Cyp1a2 and Ahr genotypes.	CYP1A2 AHR	1.41e-05	2	131	2	21571617
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CYLD IQSEC3 RANGAP1 ANK2 ANK3 DLGAP5 SYNPO TTC3 MDN1 ZNF516 ZSCAN18 HERC2 BSN MGA	1.73e-05	963	131	14	28671696
Pubmed	MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.	AFF3 CCNT1 DOT1L	1.84e-05	14	131	3	20854876
Pubmed	Expression of human-specific ARHGAP11B in mice leads to neocortex expansion and increased memory flexibility.	ARHGAP11A MKI67 TBR1	1.84e-05	14	131	3	33938018
Pubmed	F3/Contactin acts as a modulator of neurogenesis during cerebral cortex development.	CCNE1 MKI67 TBR1	1.84e-05	14	131	3	22360968
Pubmed	Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.	CYLD RANGAP1 CCNT1 MSH6 HERC2	2.03e-05	87	131	5	17148452
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CYLD CHAF1A CHD9 RREB1 NCKAP5L CREBBP ADCY9 PHF2 CCNT1 MSH6 RBM25 AHR LTK MGA TOP2A	2.13e-05	1116	131	15	31753913
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	EPRS1 ELOA ZNF185 SYNPO ARHGAP11A TRIP12 TASOR2 MSH6 RBM25 AFAP1 EIF5 MKI67 SMN1 LTV1 UHRF2 TOP2A	2.16e-05	1257	131	16	36526897
Pubmed	Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth.	ANK2 ANK3 MKI67	2.30e-05	15	131	3	30562487
Pubmed	USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c.	EPRS1 ELOA TRIP12 MSH6 MKI67	2.39e-05	90	131	5	35654790
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	PDS5B EPRS1 RANGAP1 CHAF1A TTC3 PHF2 MSH6 LIG3 RBM25 MDN1 NCAPD2 EIF5 MKI67 LTV1 BSN ATP2B1 TOP2A	2.67e-05	1425	131	17	30948266
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	RANGAP1 SYNPO ARHGAP11A JMY NCBP3 CCNE1 CRACD MSH6 LIG3 IGF2BP3 AFAP1 MDN1 NCAPD2 PEX19 MKI67 ATP2B1 TOP2A	3.04e-05	1440	131	17	30833792
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	PDXDC1 ABL2 ANK3 DTNA GPRIN1 ADCY9 MAP4K5 MID1 ATP2B1	3.30e-05	421	131	9	36976175
Pubmed	The Catalytically Inactive Mutation of the Ubiquitin-Conjugating Enzyme CDC34 Affects its Stability and Cell Proliferation.	EPRS1 RANGAP1 LARS2 MSH6 MDN1 NCAPD2 RAB13	3.40e-05	237	131	7	29564676
Pubmed	ASPM regulates symmetric stem cell division by tuning Cyclin E ubiquitination.	CCNE1 MKI67 TBR1	3.42e-05	17	131	3	26581405
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CYLD CENPT CHAF1A DLGAP5 ARHGAP11A TRIP12 CREBBP PHF2 LIG3 IGF2BP3 ZNF516	3.49e-05	645	131	11	25281560
Pubmed	A bead-based approach for large-scale identification of in vitro kinase substrates.	BIRC6 MSH6 NCAPD2 LTV1 ATP2B1 TOP2A	3.72e-05	163	131	6	22113938
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ABL2 LARS2 TTC3 CREBBP CHMP7 PEX19 TOP2A ALPK2	3.96e-05	332	131	8	37433992
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	EPRS1 RANGAP1 CHAF1A RREB1 MSH6 MDN1 NCAPD2 TOP2A	3.96e-05	332	131	8	32786267
Pubmed	Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders.	ANK2 IGF2BP3 POM121 MKI67 SMN1	4.16e-05	101	131	5	26949739
Pubmed	Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer.	MKI67 TOP2A	4.21e-05	3	131	2	27284123
Pubmed	The involvement of nuclear factor-κappaB in the nuclear targeting and cyclin E1 upregulating activities of hepatoma upregulated protein.	DLGAP5 CCNE1	4.21e-05	3	131	2	25289861
Pubmed	Interplay between mismatch repair and chromatin assembly.	CHAF1A MSH6	4.21e-05	3	131	2	22232658
Pubmed	Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.	MKI67 TOP2A	4.21e-05	3	131	2	27259241
Pubmed	Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells.	TDP1 TOP2A	4.21e-05	3	131	2	22375014
Pubmed	Generation of a 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-)_Ahrd mouse line harboring the poor-affinity aryl hydrocarbon receptor.	CYP1A2 AHR	4.21e-05	3	131	2	18814841
Pubmed	TOP2A/MCM2, p16INK4a, and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions.	CCNE1 TOP2A	4.21e-05	3	131	2	33413211
Pubmed	The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells.	ANK2 ANK3	4.21e-05	3	131	2	15611082
Pubmed	Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption.	CYP1A2 AHR	4.21e-05	3	131	2	21357676
Pubmed	Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.	MKI67 TOP2A	4.21e-05	3	131	2	23135572
Interaction	H3-3A interactions	PDS5B EPRS1 ELOA CENPT INTS12 CTDSPL2 CHAF1A POU2F1 CHD9 SYNPO RREB1 ARHGAP11A TRIP12 CREBBP NCBP3 PHF2 CCNT1 MSH6 LIG3 CCNL1 EIF5 ZSCAN18 MKI67 HERC2 DOT1L UHRF2 MGA TOP2A	1.83e-14	749	127	28	int:H3-3A
Interaction	H3C3 interactions	PDS5B ELOA INTS12 CTDSPL2 CHAF1A DLGAP5 POU2F1 RREB1 ARHGAP11A TRIP12 NCBP3 PHF2 MSH6 LIG3 CCNL1 ZSCAN18 MKI67 UHRF2 MGA TOP2A	3.88e-11	495	127	20	int:H3C3
Interaction	BRD3 interactions	PDS5B CENPT INTS12 CTDSPL2 CHAF1A CHD9 TRIP12 PHF2 LIG3 RBM25 MKI67 TBR1 DOT1L UHRF2 MGA TOP2A	8.94e-08	494	127	16	int:BRD3
Interaction	KCNA3 interactions	EPRS1 RANGAP1 ABL2 ANK2 ANK3 DTNA MAGI3 CHD9 GPRIN1 ADCY9 ASAP2 RBM25 CEP95 MAP4K5 MID1 NCAPD2 EIF5 PDZD8 LTV1 BSN ATP2B1	1.18e-07	871	127	21	int:KCNA3
Interaction	H2BC8 interactions	PDS5B ELOA CENPT CTDSPL2 CHAF1A DLGAP5 RREB1 ARHGAP11A TRIP12 NCBP3 PHF2 MSH6 LIG3 MKI67 TDP1 MGA TOP2A	1.30e-07	576	127	17	int:H2BC8
Interaction	H3C1 interactions	PDS5B EPRS1 ELOA CENPT ANK2 ANK3 CHAF1A DLGAP5 JADE1 ARHGAP11A GPRIN1 TRIP12 CREBBP MSH6 LIG3 MKI67 NAV3 LTV1 UHRF2 MGA TOP2A	2.07e-07	901	127	21	int:H3C1
Interaction	PARP1 interactions	CYLD PDS5B ELOA RANGAP1 CTDSPL2 ZNF423 POU2F1 RREB1 TRIP12 CREBBP PHF2 PSME3IP1 MSH6 LIG3 ASAP2 RBM25 MDN1 NCAPD2 MKI67 AHR LTK TDP1 UHRF2 MGA TOP2A	5.96e-07	1316	127	25	int:PARP1
Interaction	POLR1G interactions	PDS5B ELOA CHAF1A CHD9 RREB1 TRIP12 NCBP3 PHF2 LIG3 MDN1 ZNF516 DOT1L MGA TOP2A	2.58e-06	489	127	14	int:POLR1G
Interaction	SLX4 interactions	PDS5B ELOA RANGAP1 AFF3 CHD9 ARHGAP11A CREBBP CCNT1 PSME3IP1 MSH6 MDN1 ZNF516 MKI67 MGA SPTY2D1	3.25e-06	572	127	15	int:SLX4
Interaction	ARL4D interactions	PDXDC1 EPRS1 TRIP12 TASOR2 MKI67 MGA SPTY2D1 RAB13	4.06e-06	146	127	8	int:ARL4D
Interaction	ASF1A interactions	BDP1 CHAF1A RREB1 TASOR2 PHF2 CCNT1 ZNF516 DOT1L MGA SPTY2D1	4.08e-06	249	127	10	int:ASF1A
Interaction	RNF123 interactions	FAM47A EPRS1 RANGAP1 DGKA MAGI3 ARHGAP11A GPRIN1 TRIP12 BIRC6 MSH6 LIG3 IGF2BP3 MDN1 TRPM3 CEP95 AHR AKAP13 TBR1	4.18e-06	824	127	18	int:RNF123
Interaction	SMC5 interactions	PDS5B EPRS1 ELOA RANGAP1 CENPT CHAF1A DLGAP5 RREB1 TRIP12 TASOR2 NCBP3 PHF2 CCNT1 LIG3 RBM25 EIF5 MKI67 SMN1 MGA TOP2A	4.39e-06	1000	127	20	int:SMC5
Interaction	H3-4 interactions	EPRS1 CHAF1A RREB1 CREBBP PHF2 ZNF800 ZNF516 SMN1 HERC2 DOT1L MGA TSPYL4 TOP2A	5.20e-06	448	127	13	int:H3-4
Interaction	XRCC6 interactions	ELOA INTS12 RANBP3 CHAF1A POU2F1 TRIP12 CREBBP PHF2 CCNT1 MSH6 LIG3 IGF2BP3 NCAPD2 MKI67 PDZD8 NHEJ1 UHRF2 MGA TOP2A	5.61e-06	928	127	19	int:XRCC6
Interaction	TERF2IP interactions	PDS5B ELOA CHAF1A RREB1 TRIP12 CREBBP TASOR2 CCNT1 LIG3 ZSCAN18 MKI67 AHR MGA TOP2A	1.03e-05	552	127	14	int:TERF2IP
Interaction	COIL interactions	PDS5B ELOA CHD9 RREB1 NCBP3 CCNE1 PHF2 MSH6 MKI67 SMN1 DOT1L MGA SPTY2D1 TOP2A	1.03e-05	552	127	14	int:COIL
Interaction	HECTD1 interactions	PDS5B EPRS1 ELOA TRIP12 BIRC6 MAP3K1 TGOLN2 NCBP3 MSH6 LIG3 IGF2BP3 RBM25 MDN1 NCAPD2 MKI67 LTV1 HERC2 SPTY2D1 TOP2A	1.29e-05	984	127	19	int:HECTD1
Interaction	ZNF330 interactions	PDS5B ELOA CHAF1A POU2F1 RREB1 TRIP12 NCBP3 PHF2 MSH6 LIG3 SPTY2D1 TOP2A	2.57e-05	446	127	12	int:ZNF330
Interaction	CENPA interactions	PDS5B CENPT CHAF1A RREB1 TRIP12 NCBP3 PHF2 MSH6 LIG3 DOT1L TOP2A	2.72e-05	377	127	11	int:CENPA
Interaction	SSRP1 interactions	ELOA INTS12 CHAF1A JADE1 PHF2 MSH6 LIG3 IGF2BP3 LTK DOT1L TDP1 UHRF2 ATP2B1 SPTY2D1 TOP2A	2.75e-05	685	127	15	int:SSRP1
Interaction	UHRF2 interactions	INTS12 TASOR2 CCNE1 LIG3 MKI67 UHRF2 MGA TOP2A	4.00e-05	200	127	8	int:UHRF2
Interaction	SUPT5H interactions	ELOA RANGAP1 INTS12 RANBP3 JADE1 NCBP3 PHF2 CCNT1 MSH6 LTK DOT1L	5.57e-05	408	127	11	int:SUPT5H
Interaction	NFIC interactions	ELOA POU2F1 RREB1 CREBBP MKI67 TBR1 DOT1L MGA	5.64e-05	210	127	8	int:NFIC
Interaction	HDAC1 interactions	ZNF423 CHAF1A POU2F1 RREB1 BIRC6 CREBBP CCNE1 DACT1 MSH6 ZNF800 RBM25 ZNF516 NCAPD2 MKI67 SMN1 DOT1L UHRF2 MGA TOP2A	6.51e-05	1108	127	19	int:HDAC1
Interaction	PTEN interactions	EPRS1 RANGAP1 MAGI3 GPRIN1 BIRC6 CREBBP MSH6 LIG3 MDN1 EIF5 ZSCAN18 MKI67 AHR AKAP13 LTV1 ATP2B1 RAB13	7.47e-05	929	127	17	int:PTEN
Interaction	EIF3H interactions	CYLD BDP1 CHAF1A EIF5 MKI67 PDZD8 LTV1 HERC2 TOP2A	7.60e-05	282	127	9	int:EIF3H
Interaction	RPL31 interactions	CYLD PDS5B ELOA POU2F1 NCBP3 PHF2 LIG3 IGF2BP3 EIF5 MKI67 PDZD8 LTV1 SPTY2D1 TOP2A	9.99e-05	680	127	14	int:RPL31
Interaction	BRCA1 interactions	EPRS1 ELOA RANGAP1 DTNA ZNF423 CHAF1A POU2F1 CHD9 CREBBP MAP3K1 CCNE1 MSH6 IGF2BP3 AFAP1 POM121 MDN1 MKI67 AHR HERC2 TOP2A	1.05e-04	1249	127	20	int:BRCA1
Interaction	KCNE3 interactions	CENPT GPRIN1 TRIP12 DACT1 POM121 PPP1R15B RIMS4 TMEM131L RAB13	1.10e-04	296	127	9	int:KCNE3
Interaction	HBP1 interactions	CREBBP JMY ZNF800 MKI67 SMN1 TOP2A	1.29e-04	123	127	6	int:HBP1
Interaction	APEX1 interactions	PDS5B ELOA CENPT CTDSPL2 CHAF1A ZNF185 CHD9 RREB1 ARHGAP11A NKIRAS1 TTC3 TRIP12 TGOLN2 PHF2 LIG3 ZNF516 EIF5 ZSCAN18 DOT1L MGA	1.33e-04	1271	127	20	int:APEX1
Interaction	NAA40 interactions	EPRS1 ELOA RANGAP1 ANK2 RANBP3 DLGAP5 GPRIN1 CCNT1 CRACD PSME3IP1 MSH6 LIG3 IGF2BP3 EIF5 MKI67 LTV1 TOP2A	1.39e-04	978	127	17	int:NAA40
Interaction	EIF3D interactions	CYLD CHAF1A CREBBP NCAPD2 EIF5 MKI67 PDZD8 HERC2	1.60e-04	244	127	8	int:EIF3D
Interaction	NUP43 interactions	PDS5B RANGAP1 CENPT CHD9 TRIP12 TASOR2 NCBP3 PHF2 LIG3 POM121 MKI67 MGA TOP2A	1.62e-04	625	127	13	int:NUP43
Interaction	LYN interactions	ANK2 ANK3 DTNA ZNF423 GPRIN1 CREBBP ADCY9 PHF2 MAP4K5 CD72 LTV1 UHRF2 ATP2B1 SPESP1	1.81e-04	720	127	14	int:LYN
Interaction	RPL6 interactions	CYLD EPRS1 CTDSPL2 TRIP12 NCBP3 CCNT1 IGF2BP3 NCAPD2 EIF5 PDZD8 SMN1 DOT1L TOP2A	1.95e-04	637	127	13	int:RPL6
Interaction	CELSR3 interactions	TRIP12 TGOLN2 TSPYL4 LLCFC1	2.00e-04	46	127	4	int:CELSR3
Interaction	CPSF1 interactions	RANGAP1 CHAF1A ARHGAP11A TRIP12 TGOLN2 CCNT1 RBM25 DOT1L	2.16e-04	255	127	8	int:CPSF1
Interaction	LRP3 interactions	POM121 TRPM3 PPP1R15B TMEM131L	2.18e-04	47	127	4	int:LRP3
Interaction	CBX3 interactions	PDS5B ELOA CENPT CHAF1A CHD9 RREB1 TRIP12 TGOLN2 LIG3 MKI67 UHRF2 MGA TOP2A	2.24e-04	646	127	13	int:CBX3
Interaction	LTBR interactions	TGOLN2 POM121 CEP95 MKI67 MGA	2.37e-04	88	127	5	int:LTBR
Interaction	HMGA2 interactions	CHAF1A TRIP12 LIG3 IGF2BP3 MKI67 TOP2A	2.62e-04	140	127	6	int:HMGA2
Interaction	EIF3C interactions	CYLD BDP1 CHAF1A EIF5 MKI67 PDZD8 HERC2 DOT1L	2.66e-04	263	127	8	int:EIF3C
Interaction	EIF3B interactions	CYLD CHAF1A IGF2BP3 EIF5 MKI67 PDZD8 HERC2 DOT1L TOP2A	2.89e-04	337	127	9	int:EIF3B
Interaction	CHD3 interactions	EPRS1 ELOA CHAF1A CREBBP NCBP3 MSH6 LIG3 IGF2BP3 RBM25 MDN1 MKI67 DOT1L UHRF2 TOP2A	3.02e-04	757	127	14	int:CHD3
Interaction	LRRC31 interactions	EPRS1 TRIP12 MSH6 NCAPD2 AKAP13 HERC2 TBR1	3.24e-04	205	127	7	int:LRRC31
Interaction	ALK interactions	CYLD ABL2 LARS2 MAP3K1 MAP4K5 PDZD8 LTK ATP2B1	3.25e-04	271	127	8	int:ALK
Interaction	YWHAE interactions	EPN3 CYLD ELOA ABL2 CHAF1A TTC3 SHOC2 NCKAP5L TRIP12 MAP3K1 TGOLN2 CRACD IGF2BP3 CEP95 EIF5 AKAP13 DOT1L MGA TOP2A	3.28e-04	1256	127	19	int:YWHAE
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DTNA CREBBP HERC2	6.49e-05	18	80	3	91
GeneFamily	Cyclins	CCNE1 CCNT1 CCNL1	2.52e-04	28	80	3	473
GeneFamily	PHD finger proteins	INTS12 JADE1 PHF2 UHRF2	6.80e-04	90	80	4	88
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	LIG3 BSN	1.96e-03	15	80	2	26
GeneFamily	T-boxes	TBR1 MGA	2.83e-03	18	80	2	766
GeneFamily	Aminoacyl tRNA synthetases, Class I	EPRS1 LARS2	3.15e-03	19	80	2	131
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	PDS5B DLGAP5 CHD9 ARHGAP11A LARS2 SHOC2 TRIP12 CREBBP ADCY9 MSH6 IGF2BP3 ASAP2 AFAP1 MDN1 MAP4K5 MID1 NAV3 TMEM131L AKAP13 ATP2B1 TOP2A PLCE1	2.07e-10	856	129	22	M4500
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	CYLD ZC3H12A CTDSPL2 DGKA JADE1 JMY TASOR2 RBM25 MDN1 CEP95 CCNL1 PDZD8 UHRF2 ATP2B1 SPTY2D1	3.82e-09	432	129	15	M41149
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	CHD9 SHOC2 CREBBP ADCY9 CCNE1 IGF2BP3 MKI67 NAV3 AHR TMEM131L ATP2B1 TOP2A	3.22e-08	300	129	12	M8702
Coexpression	MITSIADES_RESPONSE_TO_APLIDIN_DN	PDS5B EPRS1 CHAF1A DLGAP5 TTC3 CCNE1 MSH6 MDN1 NCAPD2 MKI67 TOP2A	4.71e-08	250	129	11	M11318
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	CHD9 SHOC2 ADCY9 IGF2BP3 MKI67 NAV3 ATP2B1 TOP2A	6.26e-07	145	129	8	M1810
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL	PDS5B RANGAP1 CENPT CTDSPL2 RANBP3 CHAF1A DLGAP5 JADE1 ARHGAP11A MAP3K1 CCNE1 MSH6 IGF2BP3 NCAPD2 MKI67 TDP1 UHRF2 TOP2A	8.40e-07	939	129	18	M45768
Coexpression	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	ZNF423 CHAF1A DLGAP5 MSH6 LIG3 ZNF516 MKI67 TOP2A	1.59e-06	164	129	8	M13108
Coexpression	GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	ZC3H12A JMY TASOR2 CCNL1 EIF5 AKAP13 DOT1L UHRF2	2.08e-06	170	129	8	M6697
Coexpression	ZHONG_PFC_C2_UNKNOWN_NPC	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	2.08e-06	76	129	6	M39087
Coexpression	GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN	CYLD POU2F1 RREB1 TTC3 TASOR2 MDN1 CD72 MGA	2.58e-06	175	129	8	M2940
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	CHD9 LARS2 TRIP12 CREBBP IGF2BP3 ASAP2 AFAP1 MDN1 MAP4K5 MID1 ATP2B1 TOP2A	3.46e-06	466	129	12	M13522
Coexpression	GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP	CYLD FAM47A CHAF1A CHD9 ADCY9 DACT1 ASAP2 AFAP1	5.53e-06	194	129	8	M3540
Coexpression	GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP	PDS5B ABL2 AFF3 CCNT1 MDN1 IFT88 CEP95 AHR	6.67e-06	199	129	8	M9405
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	CHD9 GPRIN1 SHOC2 RBM25 POM121 DOT1L BSN ATP2B1	8.59e-06	206	129	8	M2817
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL	PDS5B RANGAP1 CTDSPL2 CHAF1A DLGAP5 POU2F1 JADE1 ARHGAP11A CCNE1 MSH6 NCAPD2 MKI67 TDP1 TOP2A	8.63e-06	694	129	14	M45767
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	CHD9 GPRIN1 SHOC2 RBM25 POM121 DOT1L BSN ATP2B1	9.21e-06	208	129	8	MM581
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE	ANK3 AFF3 TTC3 JMY CCNT1 RBM25 CEP95 SMN1 ATP2B1 SPTY2D1	1.31e-05	363	129	10	M41103
Coexpression	GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP	ZC3H12A ABL2 JMY TASOR2 CCNL1 ZSCAN18 AKAP13	2.03e-05	168	129	7	M6704
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	PDXDC1 CYLD ANK3 AFF3 DGKA JMY MAP3K1 CCNT1 RBM25 CEP95 CCNL1	2.36e-05	474	129	11	M40991
Coexpression	BENPORATH_NANOG_TARGETS	CYLD RANGAP1 ZFP42 INTS12 DTNA ZNF185 DLGAP5 POU2F1 JADE1 ARHGAP11A PSME3IP1 IGF2BP3 CEP95 ZNF516 NCAPD2 TOP2A	2.91e-05	988	129	16	M6616
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	RANGAP1 CENPT CTDSPL2 DLGAP5 JADE1 ARHGAP11A CCNE1 MSH6 KITLG NCAPD2 MKI67 TOP2A	2.97e-05	578	129	12	M2368
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	RANGAP1 CTDSPL2 CHAF1A DLGAP5 ARHGAP11A GPRIN1 TTC3 CCNE1 MSH6 NCAPD2 MKI67 DOT1L TOP2A	3.22e-05	680	129	13	MM456
Coexpression	MEBARKI_HCC_PROGENITOR_FZD8CRD_UP	RANGAP1 CHAF1A DLGAP5 ARHGAP11A GPRIN1 LIG3 MID1 CCDC74A NCAPD2 MKI67 TDP1 TOP2A	3.51e-05	588	129	12	M38992
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	RANGAP1 CENPT CTDSPL2 DLGAP5 JADE1 ARHGAP11A CCNE1 MSH6 KITLG NCAPD2 MKI67 TOP2A	4.06e-05	597	129	12	MM1309
Coexpression	CAIRO_HEPATOBLASTOMA_CLASSES_UP	EPRS1 CHAF1A DLGAP5 CCNE1 MSH6 LIG3 MDN1 NCAPD2 MKI67 TDP1 ATP2B1 TOP2A	5.15e-05	612	129	12	M4772
Coexpression	PUJANA_ATM_PCC_NETWORK	PDS5B CHAF1A RREB1 ARHGAP11A MAP3K1 TGOLN2 CCNE1 CHMP7 MSH6 POM121 ZNF516 NCAPD2 MKI67 ALPK3 TMEM131L CD72 SMN1 ARHGAP25 TOP2A	5.28e-05	1394	129	19	M9585
Coexpression	GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP	DGKA JADE1 PSME3IP1 ZSCAN18 PDZD8 ARHGAP25 MGA	5.44e-05	196	129	7	M3243
Coexpression	GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP	CYLD RANGAP1 TASOR2 RBM25 CEP95 CCNL1 UHRF2	5.44e-05	196	129	7	M4928
Coexpression	GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	ELOA JADE1 JMY CHMP7 TMEM131L PDZD8 LTV1	5.44e-05	196	129	7	M4244
Coexpression	GSE20727_CTRL_VS_H2O2_TREATED_DC_DN	ANK3 SYNPO TGOLN2 MAP4K5 ZSCAN18 ARHGAP25 ATP2B1	5.44e-05	196	129	7	M9243
Coexpression	GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	ELOA ZC3H12A JADE1 JMY PDZD8 LTV1 SPTY2D1	5.62e-05	197	129	7	M4237
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	PDS5B CTDSPL2 JADE1 TTC3 KITLG TRPM3 NCAPD2 AHR PDZD8 TOP2A	5.95e-05	434	129	10	M15150
Coexpression	GSE6875_WT_VS_FOXP3_KO_TREG_DN	LARS2 ASAP2 IFT88 NCAPD2 LTK TOP2A ALPK2	5.99e-05	199	129	7	M6804
Coexpression	GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN	ELOA CENPT ARHGAP11A NCBP3 CEP95 NCAPD2 NHEJ1	6.18e-05	200	129	7	M8069
Coexpression	GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP	SYNPO HOXA3 CCNE1 CHMP7 MSH6 SEBOX TBR1	6.18e-05	200	129	7	M9771
Coexpression	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN	ZC3H12A MAGI3 JMY MAP4K5 ARHGAP25 HERC2 ALPK2	6.18e-05	200	129	7	M6408
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	PDS5B ADCY9 NAV3 TMEM131L PLCE1	6.39e-05	85	129	5	M10575
Coexpression	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	RANGAP1 MAP4K5 AHR ATP2B1	7.14e-05	45	129	4	M950
Coexpression	HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	CCNE1 MKI67 TOP2A	7.53e-05	17	129	3	M9940
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	PDS5B CTDSPL2 JADE1 TTC3 KITLG TRPM3 NCAPD2 AHR PDZD8 TOP2A	7.75e-05	448	129	10	MM1044
Coexpression	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	ANK2 CHAF1A DLGAP5 CHMP7 MKI67 TOP2A	8.41e-05	145	129	6	M3045
Coexpression	WANG_TUMOR_INVASIVENESS_DN	RANGAP1 DLGAP5 TTC3 BIRC6 MAP3K1 TGOLN2 PEX19	8.64e-05	211	129	7	M1866
Coexpression	FISCHER_DREAM_TARGETS	PDS5B RANGAP1 CTDSPL2 CHAF1A DLGAP5 POU2F1 JADE1 ARHGAP11A BIRC6 CCNE1 MSH6 NCAPD2 MKI67 TDP1 TOP2A	8.70e-05	969	129	15	M149
Coexpression	BENPORATH_CYCLING_GENES	RANGAP1 CHAF1A DLGAP5 ARHGAP11A CCNE1 AFAP1 POM121 MID1 NCAPD2 MKI67 AKAP13 TOP2A	8.87e-05	648	129	12	M8156
Coexpression	WANG_TUMOR_INVASIVENESS_DN	RANGAP1 DLGAP5 TTC3 BIRC6 MAP3K1 TGOLN2 PEX19	1.03e-04	217	129	7	MM778
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	PDS5B ANK2 ANK3 POU2F1 CRACD DACT1 RIMS4 DOT1L BSN TSPYL4	1.05e-04	465	129	10	M39066
Coexpression	KONG_E2F3_TARGETS	DLGAP5 CCNE1 NCAPD2 MKI67 TOP2A	1.20e-04	97	129	5	MM1105
Coexpression	KONG_E2F3_TARGETS	DLGAP5 CCNE1 NCAPD2 MKI67 TOP2A	1.38e-04	100	129	5	M1157
Coexpression	FAN_EMBRYONIC_CTX_NSC_2	RANGAP1 DLGAP5 JADE1 ARHGAP11A NCAPD2 MKI67 TOP2A	1.60e-04	233	129	7	M39036
Coexpression	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	ANK2 CHAF1A DLGAP5 ARHGAP11A NCAPD2 TOP2A	1.65e-04	164	129	6	M19957
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	RANGAP1 CHAF1A DLGAP5 ARHGAP11A CCNE1 MSH6 NCAPD2 MKI67 TOP2A	1.74e-04	402	129	9	MM454
Coexpression	GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN	MAP3K1 CD72 AKAP13 TBR1 NHEJ1 TOP2A	1.76e-04	166	129	6	M8182
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_DN	EPRS1 ANK3 HOXA3 LIG3 POM121 CCNL1 NCAPD2 MKI67 TMEM131L MGA SPESP1	2.21e-04	610	129	11	M3854
Coexpression	KAUFFMANN_MELANOMA_RELAPSE_UP	CHAF1A MSH6 TDP1 TOP2A	2.35e-04	61	129	4	M2431
Coexpression	HEVNER_CORTEX_PROLIFERATING_CELLS	CCNE1 MKI67 TOP2A	2.47e-04	25	129	3	MM433
Coexpression	REICHERT_MITOSIS_LIN9_TARGETS	NCAPD2 MKI67 TOP2A	3.12e-04	27	129	3	M2483
Coexpression	GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_DN	FAM47A IQSEC3 ZNF185 ARHGAP11A C4orf54 AHR	3.35e-04	187	129	6	M7538
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP	DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	3.35e-04	187	129	6	M2984
Coexpression	REICHERT_MITOSIS_LIN9_TARGETS	NCAPD2 MKI67 TOP2A	3.49e-04	28	129	3	MM1323
Coexpression	HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP	DLGAP5 CCNE1 MKI67 TOP2A	3.57e-04	68	129	4	M41108
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CYLD BDP1 ANK2 ANK3 AFF3 MAGI3 POU2F1 TTC3 DACT1 MDN1 NAV3 BSN TSPYL4 ATP2B1 ICA1L	3.63e-04	1106	129	15	M39071
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM	CHAF1A DLGAP5 ARHGAP11A MID1 NCAPD2 MKI67 TDP1 TOP2A	3.78e-04	354	129	8	M39061
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_DN	EPRS1 ANK3 HOXA3 LIG3 POM121 CCNL1 NCAPD2 MKI67 TMEM131L MGA SPESP1	3.79e-04	650	129	11	MM1042
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	CYLD BDP1 PDS5B DGKA JADE1 TRIP12 BIRC6 CREBBP JMY TGOLN2 ZNF800 PPP1R15B CCNL1 EIF5 AHR TMEM131L AKAP13 ARHGAP25	3.80e-04	1492	129	18	M40023
Coexpression	GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP	ZNF423 CHD9 JADE1 JMY TSPYL4 SPTY2D1	3.85e-04	192	129	6	M4174
Coexpression	GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN	PDS5B DGKA SHOC2 CREBBP DACT1 CD72	3.96e-04	193	129	6	M6903
Coexpression	JOHNSTONE_PARVB_TARGETS_3_DN	BDP1 PDS5B ELOA IQSEC3 CTDSPL2 DLGAP5 JADE1 ARHGAP11A MSH6 LIG3 MID1 EIF5 TOP2A	3.98e-04	877	129	13	M2241
Coexpression	CROONQUIST_NRAS_SIGNALING_DN	CHAF1A EIF5 MKI67 TOP2A	3.99e-04	70	129	4	M10739
Coexpression	SENESE_HDAC1_TARGETS_UP	BDP1 EPRS1 ZC3H12A CTDSPL2 TASOR2 IGF2BP3 KITLG MAP4K5 NAV3	4.05e-04	451	129	9	M14973
Coexpression	GSE29618_BCELL_VS_MDC_UP	SYNPO SHOC2 CHMP7 EIF5 CD72 ARHGAP25	4.07e-04	194	129	6	M4943
Coexpression	GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	ELOA JMY EIF5 PDZD8 LTV1 SPTY2D1	4.07e-04	194	129	6	M4234
Coexpression	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP	ABL2 RREB1 JMY TMEM131L TSPYL4 SPTY2D1	4.18e-04	195	129	6	M4195
Coexpression	GSE29618_BCELL_VS_PDC_UP	SYNPO CHMP7 TMEM131L CD72 ARHGAP25 ATP2B1	4.30e-04	196	129	6	M4940
Coexpression	GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP	ZNF185 ARHGAP11A LARS2 TTC3 EIF5 ATP2B1	4.42e-04	197	129	6	M8166
Coexpression	GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP	ZNF423 ARHGAP11A PHF2 IGF2BP3 MKI67 ARHGAP25	4.54e-04	198	129	6	M8407
Coexpression	GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP	ZNF185 PHF2 MSH6 ZNF516 PDZD8 ARHGAP25	4.54e-04	198	129	6	M7944
Coexpression	GSE45365_NK_CELL_VS_BCELL_UP	BDP1 ABL2 TASOR2 MDN1 PPP1R15B SPTY2D1	4.54e-04	198	129	6	M10031
Coexpression	GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN	ZNF423 CHAF1A DLGAP5 ARHGAP11A CCNE1 TOP2A	4.66e-04	199	129	6	M9422
Coexpression	GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN	FOXD3 CCNL1 AHR CD72 IGSF9 HERC2	4.66e-04	199	129	6	M3738
Coexpression	GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP	CYLD ELOA DLGAP5 CCNT1 AHR UHRF2	4.66e-04	199	129	6	M8425
Coexpression	GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP	PDS5B DLGAP5 MAGI3 PHF2 MKI67 TDP1	4.66e-04	199	129	6	M7486
Coexpression	GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	PDS5B ABL2 MAGI3 NCAPD2 TMEM131L TOP2A	4.66e-04	199	129	6	M7522
Coexpression	GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN	MAGI3 CCNE1 PHF2 MKI67 TSPYL4 TOP2A	4.66e-04	199	129	6	M6205
Coexpression	GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	CYLD JADE1 TTC3 CREBBP CCNL1 AKAP13	4.66e-04	199	129	6	M7607
Coexpression	GSE360_L_MAJOR_VS_T_GONDII_MAC_DN	EPRS1 CHAF1A MSH6 IGF2BP3 POM121 MDN1	4.66e-04	199	129	6	M5246
Coexpression	GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN	BDP1 CTDSPL2 TGOLN2 CHMP7 AHR TMEM131L	4.66e-04	199	129	6	M3177
Coexpression	GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	PDS5B ABL2 AFF3 BIRC6 CREBBP AKAP13	4.78e-04	200	129	6	M291
Coexpression	GSE369_SOCS3_KO_VS_WT_LIVER_DN	CYLD AFF3 MAP3K1 NCAPD2 LTK TSPYL4	4.78e-04	200	129	6	M5963
Coexpression	GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP	CENPT DLGAP5 MSH6 SMN1 LTK TDP1	4.78e-04	200	129	6	M5990
Coexpression	GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP	TMEM53 REC114 RBM25 MAP4K5 LTK MGA	4.78e-04	200	129	6	M9397
Coexpression	GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_UP	INTS12 DLGAP5 BIRC6 TRPM3 NCAPD2 AHR	4.78e-04	200	129	6	M9333
Coexpression	GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP	ZC3H12A ANK3 JADE1 TTC3 ZNF516 ZSCAN18	4.78e-04	200	129	6	M4590
Coexpression	GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP	DGKA JADE1 PSME3IP1 ZSCAN18 PDZD8 ATP2B1	4.78e-04	200	129	6	M3251
Coexpression	GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP	EPRS1 INTS12 JADE1 RREB1 PDZD8 AKAP13	4.78e-04	200	129	6	M8497
Coexpression	HALLMARK_E2F_TARGETS	PDS5B DLGAP5 CCNE1 NCAPD2 MKI67 TOP2A	4.78e-04	200	129	6	M5925
Coexpression	HALLMARK_G2M_CHECKPOINT	PDS5B CHAF1A CCNT1 LIG3 MKI67 TOP2A	4.78e-04	200	129	6	M5901
Coexpression	GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN	NCKAP5L PPP1R15B CCNL1 TMEM131L LTV1 LTK	4.78e-04	200	129	6	M7881
Coexpression	GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN	EPRS1 POU2F1 ARHGAP11A MAP3K1 CD72 TDP1	4.78e-04	200	129	6	M6989
Coexpression	YAMAZAKI_TCEB3_TARGETS_DN	ZFP42 JADE1 CCNE1 MSH6 MDN1 TOP2A	4.91e-04	201	129	6	M1571
Coexpression	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	CYLD EPRS1 POU2F1 MAP3K1 RBM25 MAP4K5 ZSCAN18	4.96e-04	281	129	7	M7089
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	BDP1 INTS12 ANK2 CTDSPL2 DTNA POU2F1 CHD9 LARS2 CCNE1 CRACD MSH6 ZNF800 IGF2BP3 RBM25 MDN1 IFT88 MID1 EIF5 MKI67 TMEM131L NHEJ1 UHRF2 TOP2A	1.64e-06	1257	128	23	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	BDP1 INTS12 ANK2 CTDSPL2 DTNA POU2F1 CHD9 LARS2 CCNE1 CRACD MSH6 ZNF800 IGF2BP3 RBM25 MDN1 IFT88 MID1 EIF5 MKI67 TMEM131L NHEJ1 UHRF2 TOP2A	1.90e-05	1459	128	23	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	ANK3 CTDSPL2 LARS2 BIRC6 JMY NCBP3 HOXA3 LIG3 EIF5 AKAP13 MGA	1.91e-05	379	128	11	gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	BDP1 EPRS1 MAGI3 POU2F1 JADE1 TTC3 BIRC6 MSH6 ZNF800 RBM25 POM121 CCNL1 EIF5	2.03e-05	532	128	13	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	RANGAP1 ZFP42 ABL2 DTNA CHD9 JADE1 RREB1 BIRC6 CREBBP MAP3K1 RBM25 KITLG MID1 MGA ATP2B1 TOP2A	2.83e-05	806	128	16	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_500	ZFP42 ABL2 BIRC6 KITLG	5.08e-05	34	128	4	gudmap_developingGonad_e11.5_ovary + mesonephros_k5_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#2	EPRS1 CHAF1A POU2F1 MDN1 ATP2B1	7.96e-05	73	128	5	Facebase_RNAseq_e9.5_Mandibular Arch_500_K2
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	ZFP42 ABL2 CHD9 BIRC6 CREBBP MAP3K1 NCBP3 ZNF800 RBM25 KITLG MID1 SMN1 UHRF2 MGA ATP2B1	1.02e-04	804	128	15	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	BDP1 PDS5B EPRS1 CTDSPL2 ZNF423 POU2F1 CHD9 ASAP2 EIF5 MKI67 UHRF2 TOP2A	1.59e-04	564	128	12	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3	DLGAP5 IGF2BP3 MKI67 AHR TOP2A	1.64e-04	85	128	5	GSM476664_100
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2	AFF3 DLGAP5 DGKA ARHGAP11A TTC3 CCNE1 NCAPD2 MKI67 AHR TOP2A	2.44e-04	422	128	10	GSM476658_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	CHD9 CREBBP MAP3K1 NCBP3 MID1 SMN1 UHRF2 ATP2B1	2.81e-04	277	128	8	gudmap_developingGonad_e12.5_ovary_k3_1000
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	EPRS1 ANK3 DGKA TTC3 MAP3K1 CHMP7 CEP95 KIF17	3.57e-08	167	131	8	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHAF1A SPATA31A7 ARHGAP11A TRPM3 NCAPD2 MKI67 LTK TOP2A	6.67e-08	181	131	8	c18e5a3f5d99043fa3cb33e2ac33fa98cd15d3db
ToppCell	droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAF1A DLGAP5 CCNE1 MSH6 NCAPD2 MKI67 TOP2A ALPK2	8.93e-08	188	131	8	0ec2a1b0505501ba18f10a5fce68c306a6292419
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 AFF3 CHD9 SHOC2 MAP3K1 PPP1R15B ARHGAP25 ATP2B1	1.09e-07	193	131	8	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CHAF1A DLGAP5 ARHGAP11A CCNE1 MSH6 NCAPD2 MKI67 TOP2A	1.44e-07	200	131	8	04bf9e6a0fbd792b49eed63dabba5d6fafed8c07
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CHAF1A DLGAP5 ARHGAP11A CCNE1 MSH6 NCAPD2 MKI67 TOP2A	1.44e-07	200	131	8	f6b5320cdfe640a71e6e2df26f30d42e64b1c921
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 BSN TOP2A	6.75e-07	168	131	7	b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 ZSCAN18 MKI67 TOP2A	7.03e-07	169	131	7	563c267edaade0e5df192ad953801ef9768d4270
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DLGAP5 DGKA ARHGAP11A NCAPD2 MKI67 TDP1 TOP2A	7.31e-07	170	131	7	2d5e56eee0c3ce75a9641cc14dee0e0807141c32
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHAF1A CCNE1 MSH6 NCAPD2 MKI67 TOP2A ALPK2	7.61e-07	171	131	7	1eebd7138c3b20ddc1104f21615f9df0e776bbe6
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AFF3 DLGAP5 IGF2BP3 MKI67 TMEM131L CD72 TOP2A	8.22e-07	173	131	7	b7e0193fd4983cb38d1bee441f608f73ee8743b9
ToppCell	droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHAF1A DLGAP5 ARHGAP11A TRPM3 NCAPD2 MKI67 IGSF9	1.07e-06	180	131	7	43fd5c498a87bb078d101298b472656f3294686a
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAF1A DLGAP5 TRPM3 NCAPD2 MKI67 IGSF9 TOP2A	1.20e-06	183	131	7	e91f00b75d43ee6293fdd4a129b789cd95f8d11a
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAF1A DLGAP5 CCNE1 CCDC74A NCAPD2 MKI67 TOP2A	1.29e-06	185	131	7	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	ANK3 CHD9 JADE1 NCBP3 RBM25 MID1 ZSCAN18	1.29e-06	185	131	7	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZC3H12A ANK3 ADCY9 AFAP1 KITLG TRPM3 MAP4K5	1.29e-06	185	131	7	a0a629e5d2b65f670ea907bd3f5e3caf17687d8f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CHAF1A DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	1.38e-06	187	131	7	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RANGAP1 DLGAP5 JADE1 ARHGAP11A NCAPD2 MKI67 TOP2A	1.59e-06	191	131	7	0ba5b112a82e489f5a21966f78a403a7436ce73b
ToppCell	Endothelial-Endothelial-D_(cycle)\|Endothelial / shred on cell class and cell subclass (v4)	RANGAP1 DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	1.59e-06	191	131	7	a3c5a913a99f17633c140ec9ece81b73e59e0715
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RANGAP1 DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	1.59e-06	191	131	7	b978afe76754cc56e1672abca27be289bb56375b
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	RANGAP1 TGOLN2 RBM25 MDN1 CCNL1 MKI67 TOP2A	1.65e-06	192	131	7	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RANGAP1 DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	1.65e-06	192	131	7	5ef79faddb433c09ff36660d8bf7a3af5a67bf1d
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CHAF1A DLGAP5 ARHGAP11A MID1 NCAPD2 MKI67 TOP2A	1.71e-06	193	131	7	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	P03-Endothelial-proliferative_endothelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RANGAP1 DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	1.77e-06	194	131	7	22bcfb0f3f73608feb22c0847ab4d34f87aeede0
ToppCell	P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RANGAP1 DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	1.77e-06	194	131	7	5e56ce9b9fe0721be3a9e6efe1422599bb867721
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDS5B AFF3 CHD9 MKI67 TMEM131L CD72 TOP2A	1.77e-06	194	131	7	8ef0b71fef5b84cfd04973f891215333e7035d1d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 AFF3 CHD9 SHOC2 MAP3K1 ARHGAP25 ATP2B1	1.83e-06	195	131	7	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 AFF3 CHD9 SHOC2 MAP3K1 ARHGAP25 ATP2B1	1.83e-06	195	131	7	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RANGAP1 DLGAP5 ARHGAP11A KITLG NCAPD2 MKI67 TOP2A	1.83e-06	195	131	7	a838bddeed487154791b69d27a68673783ff63c0
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / Treatment groups by lineage, cell group, cell type	RANGAP1 INTS12 DLGAP5 ARHGAP11A MKI67 AHR TOP2A	1.96e-06	197	131	7	038fd92750257d43d5e980fd06d77742b543f11a
ToppCell	Transverse-T_cell-cycling_gd_T\|Transverse / Region, Cell class and subclass	CHAF1A DLGAP5 ARHGAP11A GPRIN1 NCAPD2 MKI67 TOP2A	2.02e-06	198	131	7	5131b0b7d6c4dd8872cef9f2e233f59f751b4690
ToppCell	COVID-19_Moderate-T/NK_proliferative\|COVID-19_Moderate / disease group, cell group and cell class	CHAF1A DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	2.02e-06	198	131	7	166c000fb0e19602ffdd8bf2b2f19be2c6df96a6
ToppCell	Transverse-(1)_T_cell-(18)_cycling_gd_T\|Transverse / shred on region, Cell_type, and subtype	CHAF1A DLGAP5 ARHGAP11A GPRIN1 NCAPD2 MKI67 TOP2A	2.02e-06	198	131	7	396dddf7ebad41c3a91329b6a280623c0dfdcd2f
ToppCell	Caecum-B_cell-B_cell_cycling\|B_cell / Region, Cell class and subclass	CHAF1A DLGAP5 ARHGAP11A NCAPD2 MKI67 IGSF9 TOP2A	2.02e-06	198	131	7	d2def132f3efe9305a5501a96ec82efb1f02c3f7
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHAF1A DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	2.02e-06	198	131	7	6981cd5b1585c8ae6febdf0c4fb83067127f106c
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Cycling_T\|lymph-node_spleen / Manually curated celltypes from each tissue	CHAF1A DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	2.09e-06	199	131	7	28fc342d2d178ce33203a78eb9eedae54fa9c916
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Mild / Disease, condition lineage and cell class	CHAF1A DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	2.16e-06	200	131	7	6126a3bbafe2110fba0c1c4493035df4e8193d22
ToppCell	critical-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CHAF1A DLGAP5 ARHGAP11A ASAP2 KITLG TOP2A PLCE1	2.16e-06	200	131	7	f39db4250ce220a3eb58edee3f7fc3671701d46f
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	CHAF1A DLGAP5 ARHGAP11A MSH6 NCAPD2 MKI67 TOP2A	2.16e-06	200	131	7	7e4c0db43a03ca11380a54f44a3cf1991e055b80
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	CHAF1A DLGAP5 ARHGAP11A MSH6 NCAPD2 MKI67 TOP2A	2.16e-06	200	131	7	9775ca7dedb76fcbb74f80f86b33c94e394c320a
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital\|World / Primary Cells by Cluster	BDP1 ANK2 ANK3 TTC3 DACT1 EIF5 ATP2B1	2.16e-06	200	131	7	6bbe8e1f3e91678f1bfb14945365c1578a59a604
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19\|World / Primary Cells by Cluster	BDP1 ANK2 ANK3 TTC3 DACT1 EIF5 ATP2B1	2.16e-06	200	131	7	c831d9e0a7178e3634da45548f91fa9e8dc6557c
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AFF3 ZNF185 IGF2BP3 TMEM131L CD72 TOP2A	6.90e-06	156	131	6	203ef22eb76bd2b829b027c30af0557080f4006c
ToppCell	facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REC114 DLGAP5 CCNE1 MKI67 NAV3 TOP2A	8.26e-06	161	131	6	a7e74bc80ac11250e353e5614b19c05793fc2e95
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DLGAP5 JADE1 NCAPD2 MKI67 CD72 TOP2A	9.84e-06	166	131	6	bb8135119dc37fdbba476599a56d368f422688dc
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ANK2 SYNPO HOXA3 MSH6 MKI67 TOP2A	1.02e-05	167	131	6	3461d14e36f09ddc6ee5549ca4797e16d3f37fcc
ToppCell	Control-B_cells-Activated_B_cells\|Control / group, cell type (main and fine annotations)	AFF3 CHMP7 C12orf42 TMEM131L ARHGAP25 ATP2B1	1.05e-05	168	131	6	a7159a35fe37f8c241cf8d391debe271e0698105
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	1.05e-05	168	131	6	d35944fd9fea9934ce1e76b2b35d48e2300cca61
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.05e-05	168	131	6	52fd65024af8683db11d931f7563cbe8eb815d1c
ToppCell	droplet-Trachea-3m-Hematologic-myeloid-granulocyte-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NCAPD2 MKI67 ALPK3 ARHGAP25 KIF17 TOP2A	1.16e-05	171	131	6	41932c9e70829ee3d55ca5fdb74d290fc8229416
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.16e-05	171	131	6	621f9da0bfa09c86fc89fd26919403e94cd56d2b
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ANK2 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.16e-05	171	131	6	0eea035fde32cc2a75a0d4227911edb5d54ed47e
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DLGAP5 POU2F1 CCNE1 NCAPD2 MKI67 TOP2A	1.20e-05	172	131	6	ba36581ae339191a12a6d3ead39eaf69d78be10e
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.20e-05	172	131	6	7f3d0ef18f5df1ed80498d435b0378ca398c0b88
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DLGAP5 ARHGAP11A NCAPD2 MKI67 KIF17 TOP2A	1.20e-05	172	131	6	c06ca5d075937747952ed915c9db39a9f62072f9
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 AFF3 CHD9 MAP3K1 PPP1R15B ATP2B1	1.24e-05	173	131	6	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.29e-05	174	131	6	65147b0f8c2ccadd5685430d31081520c157536a
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A PLCE1	1.29e-05	174	131	6	41eb0a214a8b4015a26311f77061c8147144f0e7
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	CHAF1A DLGAP5 ARHGAP11A GPRIN1 MKI67 TOP2A	1.33e-05	175	131	6	fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|368C / Donor, Lineage, Cell class and subclass (all cells)	CHAF1A DLGAP5 ARHGAP11A GPRIN1 MKI67 TOP2A	1.33e-05	175	131	6	36c140540497bbe1c5f08fac2d94f08cac18fabb
ToppCell	NS-critical-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DLGAP5 ARHGAP11A ASAP2 CCDC74A TOP2A PLCE1	1.37e-05	176	131	6	7cf1a06ceee1ec06532f44c729c31b4d58e5ea49
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	XIRP1 ANK2 DTNA C4orf54 ALPK3 ALPK2	1.37e-05	176	131	6	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	Control-B_cells-B_cells\|Control / group, cell type (main and fine annotations)	AFF3 MAP3K1 C12orf42 TMEM131L ARHGAP25 UHRF2	1.37e-05	176	131	6	d2c353783bd78dc24f28e00d917b88d8294fb5df
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP11A DACT1 TRPM3 MKI67 NHEJ1 TOP2A	1.42e-05	177	131	6	3e149bff1f1b393a7abe98984e37981c8296f95d
ToppCell	(01)_Cycling_Basal_(homeostasis)\|World / shred by cell type and Timepoint	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.42e-05	177	131	6	05c57578142a6662f18b294d5cc11e6efd6b0f8e
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.51e-05	179	131	6	6718cadcc2d3b64717ed84244ef1242d392662dc
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CHAF1A ARHGAP11A CCNE1 MKI67 DOT1L TOP2A	1.51e-05	179	131	6	88d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.56e-05	180	131	6	5e1680088065be14447d5d5465f91f7edd071a1e
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DLGAP5 ARHGAP11A CCNE1 MKI67 ALPK3 TOP2A	1.56e-05	180	131	6	42f48e646fc6e72ad3cce72409ace3a0b64020a2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CHAF1A DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.56e-05	180	131	6	401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.56e-05	180	131	6	ed4966765a6b25456f68185cf0648c4a3a21d7fe
ToppCell	P15-Endothelial-proliferative_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CHAF1A DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.61e-05	181	131	6	0c5bc1660b8fc1e905ab4230202862de5be46ebd
ToppCell	P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CHAF1A DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.61e-05	181	131	6	f83565f09dd971c5cad2704a4a86bca0accd955e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP5 ARHGAP11A NCAPD2 MKI67 IGSF9 TOP2A	1.66e-05	182	131	6	336cd05e46a741185ce3c59ee67a4b07fa6a5101
ToppCell	droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHAF1A DLGAP5 CCNE1 NCAPD2 MKI67 TOP2A	1.66e-05	182	131	6	11494a66d986297b837332ee9d382b71b9f22591
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP5 ARHGAP11A CCNE1 IGF2BP3 MKI67 TOP2A	1.76e-05	184	131	6	4b864c74e2cf7e58d6bd151f955c43d72f035d52
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHAF1A DLGAP5 AFAP1 NCAPD2 MKI67 TOP2A	1.76e-05	184	131	6	16aa8e88bdd51b1d132d5cf33c29963b384a8bae
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAF1A DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.82e-05	185	131	6	57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	DLGAP5 ARHGAP11A IGF2BP3 MKI67 UHRF2 TOP2A	1.82e-05	185	131	6	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.82e-05	185	131	6	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.82e-05	185	131	6	6aeae77a087d695b1e58c5f63265e7113aa2e343
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CTDSPL2 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.88e-05	186	131	6	86d145f965c311189e7996390eef491642417c5c
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDS5B DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.88e-05	186	131	6	3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDS5B DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.88e-05	186	131	6	ec6d0c29e196e374baa96dd3d506f489c959e77e
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	BIRC6 CREBBP MAP3K1 CRACD KITLG SPTY2D1	1.88e-05	186	131	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	droplet-Spleen-SPLEEN-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REC114 CHAF1A CCNE1 CCDC74A MKI67 TOP2A	1.93e-05	187	131	6	dceca7ae3dae96078cccc17a0d8a61b06fa6dffb
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ANK2 ANK3 DTNA AFF3 ALPK2 PLCE1	1.99e-05	188	131	6	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.99e-05	188	131	6	95d0a796d62ce6d121e2028c378faffc14b35275
ToppCell	MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)\|MatrixFB / shred on cell class and cell subclass (v4)	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	1.99e-05	188	131	6	b240ea20750ffb825cb5fe41d06c632233406ab6
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic\|lymph-node_spleen / Manually curated celltypes from each tissue	DLGAP5 ARHGAP11A ASAP2 MKI67 KIF17 TOP2A	1.99e-05	188	131	6	723348a1836a074e068320cb736ce6a953e0038f
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	2.05e-05	189	131	6	d049f33115610bda4489968759f754730698b9cd
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	XIRP1 ANK2 ANK3 ALPK3 AKAP13 ALPK2	2.05e-05	189	131	6	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	XIRP1 ANK2 ANK3 ALPK3 AKAP13 ALPK2	2.11e-05	190	131	6	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHAF1A DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	2.11e-05	190	131	6	b99271d139c8d01e20feb95d99f79c9b2756b4cb
ToppCell	Fetal_29-31_weeks-Immune-B_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AFF3 IGF2BP3 C12orf42 TMEM131L CD72 ARHGAP25	2.11e-05	190	131	6	424550418c1bd4eb070cf3c41cf09fa9d89aef37
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CENPT CHAF1A DLGAP5 CCNE1 MKI67 TOP2A	2.11e-05	190	131	6	638bebe200249ff6f7be764d89bd762da39ebaae
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RANGAP1 DLGAP5 ARHGAP11A NCAPD2 MKI67 TOP2A	2.11e-05	190	131	6	cd37ccd30c27cf65eda0a9165f35b7672f5acaf6
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PDS5B CHAF1A DLGAP5 ARHGAP11A NCAPD2 TOP2A	2.11e-05	190	131	6	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHAF1A DLGAP5 CCNE1 NCAPD2 MKI67 TOP2A	2.18e-05	191	131	6	239300ff76f2c855b2b04d3002461158be90a01b
ToppCell	Dividing_Macrophages-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	DLGAP5 ARHGAP11A CCNE1 NCAPD2 MKI67 TOP2A	2.18e-05	191	131	6	3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	PDS5B POU2F1 CHD9 RREB1 IGF2BP3 MID1 AKAP13 MGA ATP2B1	4.78e-07	171	126	9	7535_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	ELOA RANBP3 CHAF1A ARHGAP11A CCNE1 CHMP7 MDN1 EIF5 ATP2B1	1.21e-06	191	126	9	1059_DN
Drug	resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	PDS5B ELOA DLGAP5 ARHGAP11A LIG3 RBM25 MKI67 TOP2A	6.29e-06	176	126	8	958_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	PDS5B CHD9 CREBBP MSH6 MDN1 AKAP13 MGA ATP2B1	8.37e-06	183	126	8	7498_DN
Disease	bitter beverage consumption measurement	CYP1A2 RANGAP1 MAP4K5 AHR	2.85e-05	42	123	4	EFO_0010089
Disease	coffee consumption measurement, tea consumption measurement	CYP1A2 RANGAP1 MAP4K5 AHR	3.43e-05	44	123	4	EFO_0006781, EFO_0010091
Disease	coffee consumption, cups of coffee per day measurement	CYP1A2 MAP4K5 AHR	3.80e-05	16	123	3	EFO_0004330, EFO_0006782
Disease	nevus count, cutaneous melanoma	TASOR2 KITLG AHR HERC2 FLACC1	4.05e-05	91	123	5	EFO_0000389, EFO_0004632
Disease	Malignant neoplasm of breast	XIRP1 ANK2 POU2F1 ARHGAP11A TTC3 MAP3K1 HOXA3 CCNE1 MSH6 EIF5 MKI67 AHR HERC2 FLACC1 TOP2A	4.22e-05	1074	123	15	C0006142
Disease	Splenic Diseases	CYP1A2 AHR	5.16e-05	3	123	2	C0037997
Disease	monocyte percentage of leukocytes	RANBP3 CHD9 ADCY9 NCBP3 CCNE1 CHMP7 MAP4K5 ZNF516 AHR AKAP13 ARHGAP25 PNPLA3	5.72e-05	731	123	12	EFO_0007989
Disease	caffeine metabolite measurement	CYP1A2 MAP4K5 AHR	6.52e-05	19	123	3	EFO_0007872
Disease	neuroimaging measurement	PDXDC1 CYP1A2 ANK3 CHAF1A AFF3 RREB1 MAP3K1 CHMP7 DACT1 AFAP1 NAV3 IGSF9 ICA1L PLCE1	1.52e-04	1069	123	14	EFO_0004346
Disease	estrogen-receptor negative breast cancer	ADCY9 MAP3K1 CCNE1 FLACC1	2.25e-04	71	123	4	EFO_1000650
Disease	neutrophil percentage of leukocytes	SHOC2 TGOLN2 HOXA3 ZNF800 MAP4K5 ZNF516 AKAP13 ARHGAP25 FLACC1 TOP2A	2.46e-04	610	123	10	EFO_0007990
Disease	body surface area	PDXDC1 RREB1 TRIP12 ADCY9 CCNE1 IGF2BP3 MAP4K5 C12orf42 AKAP13 DOT1L	3.72e-04	643	123	10	EFO_0022196
Disease	coronary artery disease	PDS5B CYP1A2 MAGI3 MAP3K1 PHF2 CRACD ASAP2 TRPM3 AKAP13 PNPLA3 BSN ATP2B1 ICA1L PLCE1	4.65e-04	1194	123	14	EFO_0001645
Disease	brain measurement, neuroimaging measurement	PDXDC1 ANK3 RREB1 MAP3K1 CHMP7 DACT1 AFAP1 NAV3 IGSF9	5.11e-04	550	123	9	EFO_0004346, EFO_0004464
Disease	HbA1c measurement	ZNF185 RREB1 ADCY9 IGF2BP3 PRB4 MAP4K5 TMEM131L ARHGAP25 BSN FLACC1	5.43e-04	675	123	10	EFO_0004541
Disease	RASopathy (implicated_via_orthology)	RREB1 SHOC2	6.09e-04	9	123	2	DOID:0080690 (implicated_via_orthology)
Disease	cups of coffee per day measurement	CYP1A2 MAP4K5 AHR	6.24e-04	40	123	3	EFO_0006782
Disease	Neurodevelopmental Disorders	ANK2 TRIP12 PHF2 TBR1	6.30e-04	93	123	4	C1535926
Disease	neutrophil count	ZNF423 MAGI3 POU2F1 CHD9 RREB1 CREBBP TGOLN2 HOXA3 IGF2BP3 KITLG MAP4K5 ZNF516 AKAP13 ARHGAP25 PNPLA3	6.46e-04	1382	123	15	EFO_0004833
Disease	albuminuria	CYP1A2 AHR LTK ICA1L	6.56e-04	94	123	4	EFO_0004285
Disease	sweet beverage consumption measurement	CYP1A2 AHR	7.59e-04	10	123	2	EFO_0010090
Disease	Atrophic	CYP1A2 AHR	7.59e-04	10	123	2	C0333641
Disease	triacylglycerol 56:6 measurement	PDXDC1 MAP4K5 PNPLA3	7.72e-04	43	123	3	EFO_0010433
Disease	pigmentation disease (is_implicated_in)	KITLG HERC2	9.25e-04	11	123	2	DOID:10123 (is_implicated_in)
Disease	1-methylxanthine measurement	CYP1A2 AHR	9.25e-04	11	123	2	EFO_0021174
Disease	urinary albumin to creatinine ratio	CYP1A2 MAP4K5 AHR MGA ICA1L	9.42e-04	179	123	5	EFO_0007778
Disease	microphthalmia (implicated_via_orthology)	TRPM3 MID1	1.11e-03	12	123	2	DOID:10629 (implicated_via_orthology)
Disease	acute myeloid leukemia (implicated_via_orthology)	CREBBP TOP2A	1.11e-03	12	123	2	DOID:9119 (implicated_via_orthology)
Disease	non-alcoholic steatohepatitis	MAP4K5 PNPLA3	1.11e-03	12	123	2	EFO_1001249
Disease	mean platelet volume	PDS5B AFF3 DLGAP5 CHD9 AFAP1 TRPM3 MAP4K5 TMEM131L CD72 PNPLA3 ICA1L PLCE1	1.17e-03	1020	123	12	EFO_0004584
Disease	body mass index, fasting blood glucose measurement	RREB1 ADCY9 MAP4K5	1.27e-03	51	123	3	EFO_0004340, EFO_0004465
Disease	esophageal squamous cell carcinoma	FLACC1 PLCE1	1.30e-03	13	123	2	EFO_0005922
Disease	Liver carcinoma	CYLD CYP1A2 DLGAP5 ARHGAP11A CCNE1 IGF2BP3 MKI67 TOP2A	1.32e-03	507	123	8	C2239176
Disease	Uveal Melanoma	RREB1 HERC2 TDP1	1.42e-03	53	123	3	EFO_1000616
Disease	reticulocyte measurement	AFF3 RREB1 BIRC6 MAP3K1 ZNF800 RBM25 MAP4K5 TMEM131L AKAP13 ARHGAP25 BSN ATP2B1	1.52e-03	1053	123	12	EFO_0010700
Disease	hemoglobin A1 measurement	RREB1 IGF2BP3 MAP4K5 AHR AKAP13 ARHGAP25 MGA FLACC1	1.55e-03	520	123	8	EFO_0007629
Disease	glycoprotein measurement	CTDSPL2 MAP4K5 PNPLA3 FLACC1	1.58e-03	119	123	4	EFO_0004555
Disease	cholesteryl esters to total lipids in large VLDL percentage	PDXDC1 MAP4K5 PNPLA3	1.67e-03	56	123	3	EFO_0022250
Disease	BMI-adjusted leptin measurement	ZNF800 MAP4K5	1.75e-03	15	123	2	EFO_0007793
Disease	Adenocarcinoma of lung (disorder)	CREBBP MSH6 AHR DOT1L TOP2A	1.75e-03	206	123	5	C0152013
Disease	myeloid white cell count	ZNF423 RREB1 TGOLN2 HOXA3 CCNT1 KITLG MAP4K5 ZNF516 PNPLA3 DOT1L PLCE1	1.90e-03	937	123	11	EFO_0007988
Disease	vital capacity	INTS12 RANBP3 AFF3 RREB1 TRIP12 JMY MAP3K1 HOXA3 IGF2BP3 AHR DOT1L ICA1L PLCE1	1.98e-03	1236	123	13	EFO_0004312
Disease	liver fat measurement, liver disease biomarker	MAP4K5 PNPLA3	1.99e-03	16	123	2	EFO_0006845, EFO_0010821
Disease	response to antineoplastic agent, response to antimicrotubule agent	AHR TMEM131L	1.99e-03	16	123	2	EFO_0005260, GO_0097327
Disease	pulse pressure measurement	ANK2 ZNF423 RREB1 HOXA3 LIG3 ASAP2 RBM25 AFAP1 TRPM3 ZNF516 AKAP13 DOT1L ATP2B1 PLCE1	2.01e-03	1392	123	14	EFO_0005763
Disease	cholesterol to total lipids in IDL percentage	PDXDC1 MAP4K5 PNPLA3	2.03e-03	60	123	3	EFO_0022233
Disease	platelet measurement	DLGAP5 CHD9 TRPM3 MAP4K5 TMEM131L PNPLA3	2.11e-03	315	123	6	EFO_0005036
Disease	lysophosphatidylcholine measurement	PDXDC1 MAP4K5 MGA	2.23e-03	62	123	3	EFO_0010224
Disease	cutaneous melanoma, hair color	RREB1 MAP3K1 HERC2	2.23e-03	62	123	3	EFO_0000389, EFO_0003924
Disease	smoking cessation	RANGAP1 ANK3 BIRC6 CCNL1 BSN ICA1L	2.47e-03	325	123	6	EFO_0004319
Disease	squamous cell carcinoma	AHR HERC2 FLACC1	2.79e-03	67	123	3	EFO_0000707
Disease	triglyceride measurement, body mass index	PDXDC1 MAP4K5	2.81e-03	19	123	2	EFO_0004340, EFO_0004530
Disease	coronary artery calcification	BDP1 ANK3 DTNA POU2F1 IFT88 MAP4K5 NAV3	2.86e-03	450	123	7	EFO_0004723
Disease	fatty acid measurement, linoleic acid measurement	PDXDC1 MAP4K5 PNPLA3	2.91e-03	68	123	3	EFO_0005110, EFO_0006807
Disease	blood urea nitrogen measurement	CYP1A2 CHD9 RREB1 MAP4K5 AHR AKAP13 PLCE1	2.93e-03	452	123	7	EFO_0004741
Disease	Non-alcoholic Fatty Liver Disease	CYP1A2 AHR PNPLA3	3.16e-03	70	123	3	C0400966
Disease	Nonalcoholic Steatohepatitis	CYP1A2 AHR PNPLA3	3.16e-03	70	123	3	C3241937
Disease	saturated fatty acids to total fatty acids percentage	MAP4K5 PNPLA3	3.44e-03	21	123	2	EFO_0022305
Disease	Lung Injury	CYP1A2 AHR	3.44e-03	21	123	2	C0273115
Disease	Chronic Lung Injury	CYP1A2 AHR	3.44e-03	21	123	2	C2350344
Disease	free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	MAP4K5 PNPLA3	3.44e-03	21	123	2	EFO_0022277
Disease	monocyte count	ZC3H12A RREB1 ADCY9 HOXA3 CHMP7 KITLG MAP4K5 ZNF516 AHR TMEM131L AKAP13 ARHGAP25 PLCE1	3.48e-03	1320	123	13	EFO_0005091
Disease	breast carcinoma	PDS5B MAGI3 RREB1 ADCY9 MAP3K1 TASOR2 CCNE1 IGF2BP3 DOT1L FLACC1 SPTY2D1	3.62e-03	1019	123	11	EFO_0000305
Disease	Splenomegaly	CYP1A2 AHR	3.77e-03	22	123	2	C0038002
Disease	autism spectrum disorder (implicated_via_orthology)	CHD9 CREBBP RIMS4 TBR1	3.82e-03	152	123	4	DOID:0060041 (implicated_via_orthology)
Disease	visceral adipose tissue measurement	CYP1A2 ZFP42 TRIP12 ADCY9 CCNE1 PHF2 C12orf42	4.11e-03	481	123	7	EFO_0004765
Disease	Renal glomerular disease	CREBBP PLCE1	4.12e-03	23	123	2	C0268731
Disease	Glomerulopathy Assessment	CREBBP PLCE1	4.12e-03	23	123	2	C4521256

Protein segments in the cluster

Peptide	Gene	Start	Entry
PLPLRTKNGTSGKDS	AHR	426	P35869
QRPRTANKAPGSKGV	AFF3	531	P51826
GLSISGRDNSKKPPD	BDP1	2346	A6H8Y1
KGIEPSSEGSKPLSN	BIRC6	986	Q9NR09
KQNGKLEDNPSSGSP	CTDSPL2	121	Q05D32
ASSGSPALPRKQRDK	ABL2	616	P42684
PKKPNANLRESTTEG	ALPK2	546	Q86TB3
LKKSQAAPGSSPCRG	AFAP1	701	Q8N556
FGDPSPSSKQNGTKE	EPN3	456	Q9H201
QSGPPSGDVNSLDKK	AKAP13	121	Q12802
SAGRKGSQLSPQPQK	ALPK3	1846	Q96L96
SGLLTPPQSGKKQSS	CCNE1	391	P24864
NPKRAKLSSPGFSAN	CREBBP	11	Q92793
GTGNKRPGDPKHSSQ	CCNT1	536	O60563
PLKKSISSRLGQDPG	CD72	16	P21854
QRESKSNAATPTKGP	DOT1L	346	Q8TEK3
PSQGTPISLKRKSAG	CHAF1A	861	Q13111
KAKGLNPDGTPALST	CCNL1	316	Q9UK58
KSISNSGKARPQPGS	CCDC74A	176	Q96AQ1
KSISNSGKARPQPGS	CCDC74B	176	Q96LY2
TKLKTSPNEGLSGNP	ATP2B1	61	P20020
SAGLPSQKPKEQQRS	RANBP3	156	Q9H6Z4
KSATPSRKILDPNTG	RANGAP1	406	P46060
RRSGNGNKPPSTDLK	RAB13	176	P51153
GPPRATESQGKDSAK	REC114	161	Q7Z4M0
KLGASNSPGQPNSVK	RBM25	671	P49756
STQSTPQKGRGRPSK	PDS5B	1366	Q9NTI5
KSIPATSGKQNPTGR	PGBD4	526	Q96DM1
SKKGPRASGNLIPQE	CYP1A2	291	P05177
PKISSSLPSGNNNGK	INTS12	71	Q96CB8
ATLGSPKDTSPKRQD	ANK2	2311	Q01484
APKSVLDSTLKGPGN	MDN1	3046	Q9NU22
NGSDLPKVSTQPRSK	LTV1	406	Q96GA3
PRDQSLSPSKGENKS	MAGI3	1251	Q5TCQ9
GNEKRIPKSASAPSA	JMY	846	Q8N9B5
RTPGNSSKKPSQGSG	NCKAP5L	636	Q9HCH0
PQLPRKNSTGSSKLT	FLACC1	26	Q96Q35
GDKSPPGQASSKRAR	HOXA3	181	O43365
QGSRPPGLSKSQVKL	MGA	981	Q8IWI9
KISGASNSKPNRPSL	HERC2	3366	O95714
ADKSTPLTNKGQPRG	ASAP2	896	O43150
SFPLPGRKNKGNSNS	NKIRAS1	176	Q9NYS0
PPRAEQTNGSKGTAK	BSN	3836	Q9UPA5
SSGLKPLKSRGLQPQ	LTK	841	P29376
GPNSPSKRGNSTGIK	PDZD8	986	Q8NEN9
TPSGSRTKQRLPGQK	PDXDC1	691	Q6P996
EKGICNRPQPGLKSS	PNPLA3	251	Q9NST1
SGIATSQKKPTRLPG	NAV3	236	Q8IVL0
PSVLASGPDRKNSKT	DGKA	336	P23743
SSSNIKNRIGNKLPP	NCBP3	446	Q53F19
NRKTGNSKTQSASPP	L1RE1	6	Q9UN81
AGTLPGSKRQLQTPK	MKI67	1201	P46013
ENKGPSGSAVSRKAP	LIG3	856	P49916
ARSASPPKAKNLNGG	MSH6	61	P52701
GDPQSKQGSPTAKRE	IQSEC3	1011	Q9UPP2
RQGSPGSVSKQKPCD	IGF2BP3	181	O00425
RQKEKRINPPSSGGT	POU2F1	431	P14859
VPKPGSLKRGLNSQS	POM121	366	Q96HA1
DASGPQKRSPGDTAK	PEX19	46	P40855
LQRQPPSSKKSDGSG	CHD9	481	Q3L8U1
ILKNPPENSDSGTGK	EIF5	141	P55010
LSQSRGPASPLEAKK	IFT88	116	Q13099
NKPRTSVNADPTKGL	DACT1	356	Q9NYF0
SGDNAREKPPSSGVK	ELOA	311	Q14241
SEGGLVPSSKSPKRQ	CHMP7	431	Q8WUX9
RAGSGKAKPRQESPS	CRACD	646	Q6ZU35
KTQSSGPGLQKNSPG	CENPT	276	Q96BT3
EGPSQRLGTPKSVNK	DLGAP5	631	Q15398
STKASGGPNPKTQNG	ADCY9	661	O60503
AKGSISQSKAPDGPQ	ANK3	2691	Q12955
PPKGKRNENRATASS	CEP95	336	Q96GE4
TTQSLRGGLPKPNKA	CEP95	541	Q96GE4
KLLKTQGAGSPRSSP	DTNA	551	Q9Y4J8
ISLRGPQADPKSGQK	FAM47A	81	Q5JRC9
LNGSPGPKDGSQTEK	LLCFC1	26	Q96L11
KPKATGSTSDPGNRN	CYLD	336	Q9NQC7
KADPRASGKAQPQSG	GPRIN1	621	Q7Z2K8
SQSPKKLTRSPNNGN	ICA1L	436	Q8NDH6
PESPSAAKGIKSQGL	C4orf54	1421	D6RIA3
SAGGLAPSKPKNSLV	FOXD3	126	Q9UJU5
GANTGKSTSKRAIPP	MAP4K5	376	Q9Y4K4
QEGNKSRSARSPPGK	PRB4	231	P10163
TGPQNKPARKTSAAD	KIF17	911	Q9P2E2
TPGNTSKQGDPSKNS	MAP3K1	1066	Q13233
SGALNKFKPNRTPSI	ARHGAP11A	291	Q6P4F7
RKDPSKNQGGGLSSS	EPRS1	986	P07814
SKDSPGDVQRSKLSP	TBR1	71	Q16650
GKKSRESASPTIPNL	PHF2	531	O75151
QARGLTAKPGSKTLP	RIMS4	136	Q9H426
PSDKGRGKNCLPVNT	TMEM131L	941	A2VDJ0
RASGKSPQPQLLSNK	LARS2	706	Q15031
ARNPSPGTSAKNAEK	PLCE1	1056	Q9P212
PKPNQNLSEASGKGA	SYNPO	711	Q8N3V7
SSESGNSVKRLKPDP	PSME3IP1	161	Q9GZU8
NQGPSSKQRKPGSSS	MARCOL	266	A0A1B0GUY1
LRDESPGTSQAKGKP	SPATA31A7	626	Q8IWB4
NPAPGTRKKSSNAEV	SHOC2	76	Q9UQ13
DSSSSNRKAKNPPGD	KITLG	196	P21583
ENSRSPGNKSDNIKP	SMN1	171	Q16637
SVPSGEPGREKKSNS	SPESP1	46	Q6UW49
GTSGPLQRPQLSKVK	NHEJ1	276	Q9H9Q4
KNRKSGILSPGSECP	SEBOX	76	Q9HB31
KRDPLQNSPGSEGKT	JADE1	596	Q6IE81
GREKPAAPTAQKSLS	PPP1R15B	111	Q5SWA1
NKAKSPGVRQPGSSS	SPTY2D1	361	Q68D10
KGPAASTQEKNPRES	NCAPD2	571	Q15021
GQAGSQRAPSAKKPS	NCAPD2	1306	Q15021
QPLSSPKKNSGSAAR	C12orf42	201	Q96LP6
SGEGVPPNRKNTKTS	C15orf32	21	Q32M92
LQDESPGTSQAKGKP	SPATA31A3	626	Q5VYP0
DGQSRGKTPLKNGSS	UHRF2	156	Q96PU4
PNRSGAEAKTQKDSP	TGOLN2	151	O43493
SNTDSVLPPKRQKSG	TDP1	66	Q9NUW8
TQGPLAKPRQEASSK	ZNF516	901	Q92618
KDKNGRRPSPSSQSS	ZC3H12A	351	Q5D1E8
LRDESPGTSQAKGKP	SPATA31A1	626	Q5TZJ5
LRDESPGTSQAKGKP	SPATA31A5	626	Q5VU36
TENGGSPQGIKSPSK	RREB1	31	Q92766
NPFQRSKSSKPEGRG	TRPM3	1696	Q9HCF6
LASPNSETGPGKKNS	ARHGAP25	531	P42331
SRSSEPGKLKTNSQP	MID1	471	O15344
KNSPSPGGKEAETRQ	TMEM53	21	Q6P2H8
SEDGQPKGVSSNSPK	TTC3	1266	P53804
TKAGQEDAPPSTKGL	TSPYL4	86	Q9UJ04
GSPDSVAKLKLQGSP	IGSF9	796	Q9P2J2
APSGAKPRQGKSSQD	ZFP42	21	Q96MM3
TKRDPALNSGVSQKP	TOP2A	1441	P11388
QQPAPDRGTAKLGTK	ZSCAN18	356	Q8TBC5
TSPSAAGGQQKTRKP	ZNF800	461	Q2TB10
QKGELLPNPSSDRKS	TASOR2	591	Q5VWN6
GSTPDSTLKPLRGQK	ZNF423	381	Q2M1K9
KVQRPPTLLGGKNTS	nan	56	Q5VSD8
ETSKPGPSGLQAKLA	TRIP12	286	Q14669
QRTPGGSQTKTPKLD	XIRP1	1301	Q702N8
PKANGTPKSAASLVR	ZNF185	106	O15231